Next-generation ovarian cancer therapy: Engineered Vδ2 T cells show promise in preclinical trials

A prospective path for allogeneic cellular immunotherapies.

Cannabis on the mind: Study finds connection between sleep, memory and marijuana use – The Cannabist

Miriam Fauzia, The Dallas Morning News DALLAS — As public support for marijuana decriminalization grows, new research is shedding light on the drug’s impact on

October 22, 2024

BD gains FDA clearance to relaunch Alaris infusion pump after recalls

Dive Brief: The Food and Drug Administration has granted Becton Dickinson 510(k) clearance for its updated Alaris infusion pump, paving the way for the company

July 24, 2023

Health Canada approves MSD’s Keytruda for NSCLC stages

MSD’s Keytruda initially gained approval in Canada in 2015. Credit: JHVEPhoto/Shutterstock. Health Canada has approved MSD’s anti-programmed cell death protein 1 (PD-1) therapy Keytruda for treating

February 12, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.